Abstract
Purpose
Adequate post-cesarean delivery analgesia can be difficult to achieve for women diagnosed with opioid use disorder receiving buprenorphine. We sought to determine if neuraxial clonidine administration is associated with decreased opioid consumption and pain scores following cesarean delivery in women receiving chronic buprenorphine therapy.
Methods
This was a retrospective cohort study at a tertiary care teaching hospital of women undergoing cesarean delivery with or without neuraxial clonidine administration while receiving chronic buprenorphine. The primary outcome was opioid consumption (in morphine milligram equivalents) 0–6 h following cesarean delivery. Secondary outcomes included opioid consumption 0–24 h post-cesarean, median postoperative pain scores 0–24 h, and rates of intraoperative anesthetic supplementation. Multivariable analysis evaluating the adjusted effects of neuraxial clonidine on outcomes was conducted using linear regression, proportional odds model, and logistic regression separately.
Results
196 women met inclusion criteria, of which 145 (74%) received neuraxial clonidine while 51 (26%) did not. In univariate analysis, there was no significant difference in opioid consumption 0–6 h post-cesarean delivery between the clonidine (8 [IQR 0, 15]) and control (1 [IQR 0, 8]) groups (P = 0.14). After adjusting for potential confounders, there remained no significant association with neuraxial clonidine administration 0–6 h (Difference in means 2.77, 95% CI [− 0.89 to 6.44], P = 0.14) or 0–24 h (Difference in means 8.56, 95% CI [− 16.99 to 34.11], P = 0.51).
Conclusion
In parturients receiving chronic buprenorphine therapy at the time of cesarean delivery, neuraxial clonidine administration was not associated with decreased postoperative opioid consumption, median pain scores, or the need for intraoperative supplementation.
Similar content being viewed by others
References
Hirai AH, Ko JY, Owens PL, Stocks C, Patrick SW. Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010–2017. JAMA. 2021;325(2):146–55.
Centers for Disease Control and Prevention, National Center for Health Statistics. Multiple Cause of Death 1999–2017 on CDC WONDER Online Database. Atlanta: Centers for Disease Control and Prevention; 2020.
Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid use disorder documented at delivery hospitalization—United States, 1999–2014. MMWR Morb Mortal Wkly Rep. 2018;67(31):845–9.
Maeda A, Bateman BT, Clancy CR, Creanga AA, Leffert LR. Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes. Anesthesiology. 2014;121(6):1158–65.
Committee Opinion No. 711. Opioid use and opioid use disorder in pregnancy. Obstet Gynecol. 2017;130(2):e81–94.
Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O’Grady KE, Selby P, Martin PR, Fischer G. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363(24):2320–31.
Zedler BK, Mann AL, Kim MM, Amick HR, Joyce AR, Murrelle EL, Jones HE. Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child. Addiction. 2016;111(12):2115–28.
Walsh SL, Eissenberg T. The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend. 2003;70(2 Suppl):S13-27.
Meyer M, Paranya G, Norris AK, Howard D. Intrapartum and postpartum analgesia for women maintained on buprenorphine during pregnancy. Eur J Pain. 2010;14(9):939–43.
Tith S, Bining G, Bollag L. Management of eight labor and delivery patients dependent on buprenorphine (SubutexTM): a retrospective chart review. F1000Res. 2018;7:7.
Eisenach JC, Pan PH, Smiley R, Lavand’homme P, Landau R, Houle TT. Severity of acute pain after childbirth, but not type of delivery, predicts persistent pain and postpartum depression. Pain. 2008;140(1):87–94.
Moriyama K, Ohashi Y, Motoyasu A, Ando T, Moriyama K, Yorozu T. Intrathecal administration of morphine decreases persistent pain after cesarean section: a prospective observational study. PLoS ONE. 2016;11(5): e0155115.
Babazade R, Vadhera RB, Krishnamurthy P, Varma A, Doulatram G, Said GR, Turan A. Acute postcesarean pain is associated with in-hospital exclusive breastfeeding, length of stay and post-partum depression. J Clin Anesth. 2020;62: 109697.
Paech MJ, Pavy TJG, Orlikowski CEP, Yeo ST, Banks SL, Evans SF, Henderson J. Postcesarean analgesia with spinal morphine, clonidine, or their combination. Anesth Analg. 2004;98(5):1460–6.
Neves JF, Monteiro GA, Almeida JR, Sant’anna RS, Saldanha RM, Moraes JMS, Nogueira ES, Coutinho FL, Neves MMP, Araujo FP, Nobrega PB. Postoperative analgesia for cesarean section: does the addition of clonidine to subarachnoid morphine improve the quality of the analgesia? Rev Bras Anestesiol. 2006;56(4):370–6.
Crespo S, Dangelser G, Haller G. Intrathecal clonidine as an adjuvant for neuraxial anaesthesia during caesarean delivery: a systematic review and meta-analysis of randomised trials. Int J Obstet Anesth. 2017;32:64–76.
Filos KS, Goudas LC, Patroni O, Polyzou V. Intrathecal clonidine as a sole analgesic for pain relief after cesarean section. Anesthesiology. 1992;77(2):267–74.
Allen TK, Mishriky BM, Klinger RY, Habib AS. The impact of neuraxial clonidine on postoperative analgesia and perioperative adverse effects in women having elective caesarean section—a systematic review and meta-analysis. Br J Anaesth. 2018;120(2):228–40.
Paech MJ, Pavy TJG, Orlikowski CEP, Evans SF. Patient-controlled epidural analgesia in labor: the addition of clonidine to bupivacaine-fentanyl. Reg Anesth Pain Med. 2000;25(1):34–40.
Landau R, Schiffer E, Morales M, Savoldelli G, Kern C. The dose-sparing effect of clonidine added to ropivacaine for labor epidural analgesia. Anesth Analg. 2002;95(3):728–34.
Hoyt MR, Shah U, Cooley J, Temple M. Use of epidural clonidine for the management of analgesia in the opioid addicted parturient on buprenorphine maintenance therapy: an observational study. Int J Obstet Anesth. 2018;34:67–72.
Cook MI, Kushelev M, Coffman JH, Coffman JC. Analgesic outcomes in opioid use disorder patients receiving spinal anesthesia with or without intrathecal clonidine for cesarean delivery: a retrospective investigation. J Pain Res. 2022;15:1191–201.
Eisenach JC, Hood DD, Curry R. Intrathecal, but not intravenous, clonidine reduces experimental thermal or capsaicin-induced pain and hyperalgesia in normal volunteers. Anesth Analg. 1998;87:591–6.
Hassenbusch SJ, Gunes S, Wachsman S, Willis KD. Intrathecal clonidine in the treatment of intractable pain: a phase I/II study. Pain Med. 2002;3:85–91.
Siddall PJ, Molloy AR, Walker S, Mather LE, Rutkowski SB, Cousins MJ. The efficacy of intrathecal morphine and clonidine in the treatment of pain after spinal cord injury. Anesth Analg. 2000;91:1493–8.
Glynn C, Dawson D, Sanders R. A double-blind comparison between epidural morphine and epidural clonidine in patients with chronic non-cancer pain. Pain. 1988;34:123–8.
Rack RL, Eisenach JC, Jackson K, Young LD, Southern J. Epidural clonidine treatment for refractory reflex sympathetic dystrophy. Anesthesiology. 1993;79:1163–9.
Eisenach JC, DuPen S, Dubois M, Miguel R, Allin D. Epidural clonidine analgesia for intractable cancer pain. The epidural clonidine study group. Pain. 1995;61:391–9.
Greenwald MK, Comer SD, Fiellin DA. Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy. Drug Alcohol Depend. 2014;144:1–11.
Young JL, Lockhart EM, Baysinger CL. Anesthetic and obstetric management of the opioid dependent parturient. Int Anesthesiol Clin. 2014;52(2):67–85.
Pan PH. Post cesarean delivery pain management: multimodal approach. Int J Obstet Anesth. 2006;15(3):185–8.
Cavens L, Roofthooft E. Neuraxial labor analgesia: is there a place for neuraxial adjuvants beyond opioids. Best Pract Res Clin Anaesthesiol. 2022;36(1):31–6.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
About this article
Cite this article
Taylor, M.G., Bauchat, J.R., Sorabella, L.L. et al. Neuraxial clonidine is not associated with lower post-cesarean opioid consumption or pain scores in parturients on chronic buprenorphine therapy: a retrospective cohort study. J Anesth 38, 339–346 (2024). https://doi.org/10.1007/s00540-024-03314-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-024-03314-8